recently
Gu Zhongze, Dean of Suzhou Medical Device Research Institute, Southeast University
Because of its outstanding achievements in the field of medicine and Bioengineering
Elected to the American Academy of medicine and Bioengineering
On March 24, 2020, the American Academy of medicine and bioengineering published a list of 156 members who were elected as members of the American Academy of medicine and bioengineering in 2020 on its official website (https://aimbe.org/2020-fellows/), and President Gu Zhongze was also on the list.
The American Institute for medical and Biological Engineering (abbreviated to "aim") is affiliated to the American Academy of Sciences. It is a famous non-profit academic organization in the field of international medicine and Bioengineering, bringing together the world's top academic elites in the field of biomedical engineering 2%), as well as the most innovative and characteristic scholars and engineers in the field of medicine and Bioengineering, which have important influence in biomedical instruments, medical devices, disease treatment and the formulation of relevant public health policies. The aim fellow is composed of the most outstanding scholars in the field of medicine and bioengineering in the world. It is recommended and strictly selected by the international peers every year. It is recommended by the existing fellow. After two rounds of screening, the last round must be voted by all the existing fellows, and it can be elected only when it obtains more than 74.5% affirmative votes. It is the highest academic honor in the field of medicine and bioengineering technology in the United States.
President Gu graduated from the Department of biomedical engineering of Southeast University in 1989. Now he is the dean of the school of biological science and medical engineering of Southeast University and the dean of Suzhou Medical Device Research Institute of Southeast University. He has published more than 270 papers on international core journals on research achievements such as human organ chips and photonic crystal materials. He has cited more than 10000 times and obtained dozens of patent authorizations. He has won many awards such as the May 4th Youth Medal of Jiangsu Province, the first prize of natural science of the Ministry of education, and the first prize of science and technology of Jiangsu Province. In 2003, he was selected into the Yangtze River Scholar Award program of the Ministry of education. Presided over a number of scientific research projects, such as the key scientific issues of transformative technology in the national key R & D plan, 863 high tech research and development plan, and the national fund for Distinguished Young Scholars.
Suzhou Institute of medical devices, Southeast University
Founded in 2017 by Jiangsu Industrial Technology Research Institute, Southeast University and Suzhou high tech Zone, relying on the leading biomedical engineering discipline strength of Southeast University, it has gathered industry elites such as Yangtze River scholars, national experts of thousands of people and foreign senior researchers, focusing on bionic organ and organ chips, biomedical materials, image big data, IVD and detection technology Through in-depth research and development, after three years of scientific research precipitation, the research institute has made gratifying progress in a number of products under research.
Revolutionary frontier technology: human organ chip
The research and development center of biomimetic organ and organ chip, led by President Gu, is mainly engaged in the chip research and Application Research of human micro organ with certain physiological functions, including tumor chip, blood vessel chip, heart chip, skin chip and other unit tissue and organ chips.
At present, the first generation of tumor chip and its three-dimensional high-content detection system have been successfully developed, and have cooperated with Hengrui, Xiansheng, Zhengda Tianqing and other pharmaceutical companies, with good results, and have been tried in Nanjing Brain Hospital, Zhongda Hospital and other top three hospitals, and have been widely praised.
Strategic basic material -- degradable medical magnesium alloy
Biomedical materials center is mainly engaged in the research and development of degradable medical magnesium alloy materials, which is the strategic direction of biomedical industry in the future, including magnesium alloy pipes, micro scaffolds, 3D printing polymer material scaffolds, etc.
At present, the research institute has developed a relatively mature manufacturing process of magnesium alloy pipes, designed and prepared 3D printing composite scaffolds, and reached a cooperation agreement with Changzhou Second People's Hospital Affiliated to Nanjing Medical University and Jiangsu aogem Biotechnology Co., Ltd. This year, the Research Institute will further optimize the process and adopt a variety of surface modification methods to enhance the physical and chemical properties of the phase surface.
The biomedical industry now stands on the industry tuyere, which is obvious. If we want to keep the tide forever and keep the tuyere open, talent is the most important part of the development of biomedical industry. With the help of the local policy advantages of Suzhou high tech Zone and its own wild goose effect, the research institute has attracted a number of industry leaders to settle in Suzhou, making the industry run out of speed and realizing the cluster advantage of 1 + 1 > 2.
In three years, the Research Institute, taking the provincial-level mass innovation space as the platform springboard, has attracted 19 district level leading entrepreneurship talents, 3 municipal level leading entrepreneurship talents, incubated 15 science and technology-based enterprises, cultivated high-tech enterprises and potential enterprises with an annual income of millions, and jointly helped the development of local biomedical Enterprises.
At the same time, the research institute seizes the opportunity of Jiangsu medical registrant system pilot, builds an industrial acceleration platform, closely integrates with its own engineering transformation platform, and improves the research and development of medical products and the process of registration and listing. In addition, Yuyue medical, a leading enterprise, has established an industrial talent training center to form a sound medical innovation ecosystem from product research and development to accelerated transformation of achievements and then to industrial cultivation.
Future
The Research Institute will further develop its scientific research strength
Continuously enlarge the effect of Talent Gathering
Continue to believe in benefiting human health
With a more passionate and open attitude
Welcome more resource subjects to exchange and cooperate
Seize the opportunity given by the times
Join hands to realize the mission of medical power
To protect human health side by side.
- END -